Xarelto FDA approval : The Janssen Pharmaceutical Companies of Johnson & Johnson has secured approval from the US Food and Drug Administration (FDA) for Xarelto (rivaroxaban) for the prevention of…
Alexion acquisition of Achillion : Alexion Pharmaceuticals has agreed to acquire rival US pharma company Achillion Pharmaceuticals for about $930 million in an all-cash deal as per the latest pharma…
Denovo Biopharma has secured approval from the US Food and Drug Administration (FDA) to launch its phase 2b clinical trial of DB102 in patients with newly-diagnosed glioblastoma (GBM) in combination…
Kodiak Sciences said that it has treated the first patients in the phase 2 DAZZLE clinical trial of KSI-301, its investigational intravitreal anti-VEGF antibody biopolymer conjugate, in wet age-related macular…
Chinese pharma company Kangpu Biopharmaceuticals said that it has wrapped up the first-in-human phase 1 clinical trial of CRL4-CRBN modulator KPG-818 in the US. KPG-818 is being developed for the…
US radioisotopes manufacturer SHINE Medical Technologies has formed a new business division called SHINE Therapeutics in a move to boost its ability to focus on addressing critical future needs in…
Agilent Technologies opens molecular spectroscopy hub in Oxfordshire
Agilent Technologies has opened a new facility for the research and development of molecular spectroscopy at the Harwell Science and Innovation Campus in Oxfordshire, UK. Expected to be…
Agilent acquires BioTek Instruments for $1.16bn
Agilent acquisition of BioTek : US-based lab instrument manufacturer Agilent Technologies has wrapped up its previously announced $1.16 billion acquisition of life science instrumentation manufacturer BioTek Instruments. The…
Alcon launches PanOptix trifocal intraocular lens for cataract patients in US
Alcon has commercially launched AcrySof IQ PanOptix trifocal intraocular lens (IOL) in the US after its approval by the US Food and Drug Administration (FDA). PanOptix is said…
SHINE raises capital for medical isotope production facility from Oaktree
SHINE Medical Technologies has secured $50 million financing with funds managed by Oaktree Capital Management to support its upcoming medical isotope production facility and the commercialization of molybdenum-99…
Alexion to acquire Achillion to strengthen rare diseases portfolio
Alexion acquisition of Achillion : Alexion Pharmaceuticals has agreed to acquire rival US pharma company…
Radioisotopes manufacturer SHINE Medical Technologies creates pharma unit
US radioisotopes manufacturer SHINE Medical Technologies has formed a new business division called SHINE Therapeutics…
CMAB Biopharma, BJ Bioscience join forces for bi-functional antibody BJ-005
CMAB Biopharma (Suzhou), a pure-play biologics CDMO, and BJ Bioscience have signed an agreement for…
Boehringer Ingelheim expands pets vaccines production facility in Athens
German pharma giant Boehringer Ingelheim has wrapped up the $76 million expansion of its pets…
Icosavax, a new vaccine development company, launched in Seattle
Icosavax, a new pharma company, focused on developing vaccines against infectious diseases, has been launched…
Elicio raises $33m to advance lymph node-targeted immuno-therapies
US immuno-oncology company Elicio Therapeutics has raised $33 million through a Series B financing round…
Sobi to acquire US pharma company Dova Pharmaceuticals in $915m deal
Sobi acquisition of Dova Pharmaceuticals : Swedish Orphan Biovitrum (Sobi) has signed a deal worth…
Latest Pharma News
-
Janssen bags Xarelto FDA approval to prevent blood clots in acutely ill patients
-
Alexion to acquire Achillion to strengthen rare diseases portfolio
-
Denovo Biopharma gets FDA approval to launch phase 2b GBM trial for DB102
-
DAZZLE clinical trial : Kodiak Sciences doses first patients with KSI-301 in phase 3 wet AMD trial
-
Kangpu wraps up phase 1 clinical trial of CRL4-CRBN modulator KPG-818
-
Radioisotopes manufacturer SHINE Medical Technologies creates pharma unit
-
Agilent Technologies opens molecular spectroscopy hub in Oxfordshire
-
Agilent acquires BioTek Instruments for $1.16bn
-
Alcon launches PanOptix trifocal intraocular lens for cataract patients in US
-
CMAB Biopharma, BJ Bioscience join forces for bi-functional antibody BJ-005
